Table 1.
The characteristics of the patients and the indexes.
| Characteristics | n or means | Percentages or stds | Minimums | Maximums |
|---|---|---|---|---|
| Male | 59 | 59% | — | — |
| Ages, yrs | 45.04 | 10.65 | 21 | 65 |
| PASI | 7.91 | 2.96 | 1.30 | 17.60 |
| BSA (%) | 9.57 | 2.84 | 3.00 | 17.00 |
| SCC-Ag (ng/mL) | 20.94 | 28.78 | 1.17 | 143.69 |
| TNF-α (pg/mL) | 9.38 | 4.49 | 3.70 | 41.70 |
| C3 (g/L) | 0.91 | 0.20 | 1.71 | 0.48 |
| C4 (g/L) | 0.47 | 2.38 | 0.13 | 24.00 |
| IL-23 (pg/mL) | 912.43 | 210.94 | 509.99 | 1446.99 |
| IL-22 (pg/mL) | 5.73 | 3.96 | 2.62 | 27.93 |
| IL-17 (pg/mL) | 5.07 | 1.77 | 1.93 | 9.11 |
| IL-10 (pg/mL) | 4.77 | 0.86 | 2.90 | 7.90 |
| DLQI | 5.58 | 3.18 | 0 | 15.00 |
| SAS | 36.75 | 9.13 | 25.00 | 68.75 |
| SDS | 32.44 | 10.10 | 25.00 | 80.00 |
| XQ | 16.20 | 9.31 | 0 | 43.00 |
| CCS | 9.74 | 4.97 | 0 | 21.00 |
| PSQI | 9.28 | 5.67 | 0 | 21.00 |
Stds, standard deviations; PASI, psoriasis area and severity index; BSA, body surface area; SCC-Ag, squamous cell carcinoma antigen; TNF-α, tumor necrosis factor-α; C3, complement 3; C4, complement 4; IL, interleukin; DLQI, Dermatology Life Quality Index; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; XQ, Xerostomia Questionnaire; CCS, Cleveland Clinic Score; PSQI, Pittsburgh Sleep Quality Index.